Lookup NU author(s): Dr Maria Lastowska,
Dr Nicholas Bown,
Professor John Lunec,
Professor Tom Strachan,
Professor Andrew Pearson,
Dr Michael Jackson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
It has recently been recognized that unbalanced translocations resulting in the gain of material from 17q are the most common chromosomal changes in neuroblastoma. These rearrangements are associated with established indicators of bad prognosis and poor patient survival. We have used 13 fluorescence in situ hybridization (FISH) probes to map 12 translocation breakpoints on 17q in 10 neuroblastoma cell lines, identifying at least seven different breakpoints, all localized within the proximal half of 17q (268- 369 cR, 53-68 cM). These results suggest that the dosage of a gene, or genes, in 17q22-qter is responsible for the clinical effects of 17q gain, rather than the disruption of a specific gene. This region contains two genes, nm23- H1 and NGFR, already implicated in neuroblastoma biology.
Author(s): Lastowska, M., Van Roy, N., Bown, N.P., Speleman, F., Lunec, J., Strachan, T., Pearson, A.D.J., Jackson, M.S.
Publication type: Article
Publication status: Published
Journal: Genes Chromosomes and Cancer
Print publication date: 01/10/1998
ISSN (print): 1045-2257
ISSN (electronic): 1098-2264
PubMed id: 9739014